Antioxidant and Anti-Inflammatory Profiles of Spent Coffee Ground Extracts for the Treatment of Neurodegeneration
Table 1
HPLC-MS/MS acquisition parameters, working as a dynamic “multiple reaction monitoring” mode, including retention time (Rt) and delta retention time (Δ Rt) for each transition.
No.
Compounds
Precursor ion (m/z)
Product ion (m/z)
Fragmentor (V)
Collision energy (V)
Polarity
Retention time (Rt) (min)
Delta retention time (Δ Rt)
1
Shikimic acid
173
173
87
0
Negative
1.40
3
—
—
—
—
2
Gallic acid
169
125a
92
12
Negative
2.37
3
51
36
3
Loganic acid
375
213a
126
8
Negative
3.13
3
113
16
4
3-Caffeoylquinic acid
353
191a
102
12
Negative
3.58
3
179
12
5
Swertiamarin
419
179a
100
4
Negative
4.89
3
89
16
6
Gentiopicroside
357
177a
50
10
Positive
5.33
3
73
28
7
(+)-Catechin
289
245a
121
8
Negative
5.48
3
109
24
8
Delphinidin-3,5-diglucoside
463
300a
165
24
Negative
5.64
3
271
48
9
Sweroside
403
125a
102
12
Negative
5.95
3
179
4
10
5-Caffeoylquinic acid
353
191a
92
12
Negative
6.22
3
85
48
11
Caffeine
195
138a
107
20
Positive
6.50
3
110
24
12
Cyanidin-3-glucoside
449
287a
121
20
Positive
6.50
3
403
16
13
Vanillic acid
167
108a
78
16
Negative
6.70
3
152
8
14
Caffeic acid
179
135a
87
12
Negative
6.87
3
134
24
15
(-)-Epicatechin
289
245a
126
8
Negative
7.03
3
109
20
16
Syringic acid
197
182a
92
8
Negative
7.48
3
123
20
17
p-Coumaric acid
163
119a
83
12
Negative
8.47
3
93
32
18
Ferulic acid
193
134a
88
12
Negative
9.16
3
178
8
19
3,5-Dicaffeoylquinic acid
515
353a
117
8
Negative
9.82
3
191
28
20
Quinine
325
79a
135
44
Positive
10.1
5
81
32
21
Naringin
579
271a
210
32
Negative
10.17
3
151
48
22
Rutin
609
300a
195
40
Negative
10.34
3
271
50
23
Hyperoside
463
300a
160
24
Negative
10.43
3
271
44
24
trans-Cinnamic acid
149
131a
44
8
Positive
10.79
3
77
36
25
Resveratrol
227
185a
131
12
Negative
10.92
3
143
20
26
Amarogentin
585
227a
145
16
Negative
11.05
3
245
16
27
Kaempferol-3-glucoside
447
284a
163
24
Negative
11.24
3
227
50
28
Quercitrin
447
300a
155
24
Negative
11.24
3
301
16
29
Quercetin
301
151a
126
16
Negative
13.03
3
179
12
30
Isogentisin
257
242a
116
16
Negative
16.31
3
214
24
aThese product ions were used for quantification; the others to confirm the analytes.